Microbiome

Innovating to Target the Microbiome for Human Health

Servatus

LBPs

Exploring the Microbiome with Servatus

Servatus

Microbiome

Modifying the Gut Microbiome to Improve CAR-T, HSCT, and Other Therapeutic Responses

Stacy Burns-Guydish, Ph.D.

List Labs

Microbiome Therapeutic Innovation

Unleashing the Power of the Microbiome: Advancements, Challenges, and the Therapeutic Future

Stacy Burns-Guydish, Ph.D.; Gary Henderson

List Labs

Microbiome-Based CDMO

Expanding a Leadership Position in Microbiome-Based Contract Development and Manufacturing

Stacy Burns-Guydish, Ph.D.; Jonathan Yongwan Jo; Gary Henderson; Michael Kimble

List Labs

Live Biotherapeutic Products

Enabling the Commercialization of Microbiome Live Biotherapeutic Products with Fit-for-Purpose Cryopreservatives

Aaron B. Cowley, Ph.D.; Nicole O'Brien, Ph.D.

ReciBioPharm

Live Biotherapeutic Products

Design Considerations for Live Biotherapeutic Product Facilities Working with Spore-Forming Bacteria

Aaron B. Cowley, Ph.D.; Judith Bodette; Brian Duffy

ReciBioPharm

Live Biotherapeutic Products

Framing the Narrative on CMC Development for Microbiome Therapeutics

Aaron B. Cowley, Ph.D.; Melanie Cerullo; Jeff Heiser

ReciBioPharm

Microbiome

Selecting a Microbiome CDMO Partner for the Long Term

Dave Stevens; Jason Rahal

Arranta Bio

Microbiome

Supporting Commercialization of Live Biotherapeutic Products for Microbiome-Based Therapies

Mark Bamforth

Arranta Bio